Literature DB >> 26311010

Levamisole-contaminated cocaine: a hairy affair.

Tjeerd van der Veer1, Ed Pennings2, J W Cohen Tervaert3, Lindy-Anne Korswagen4.   

Abstract

Levamisole-contaminated cocaine can induce severe systemic vasculitis. The diagnosis can be challenging, especially when substance abuse is uncertain. We present the case of a 42-year-old woman suffering from vasculitis due to levamisole-contaminated cocaine, who persistently denied substance abuse. Symptoms included ulcerating skin lesions, arthralgia and myalgia, and the occurrence of an ileal intussusception. The definitive diagnosis was made using hair testing for toxins. She recovered through cocaine abstinence, but re-exposure resulted in a severe relapse with glomerulonephritis. Importantly, at time of the relapse, the patient became positive for both myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA) and proteinase 3-ANCA. Cocaine-levamisole-induced vasculitis poses a great clinical challenge. The proper diagnostic strategy and therapy is still controversial. We highlight our diagnostic and therapeutic considerations, including hair testing for definitive proof of exposure. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26311010      PMCID: PMC4550939          DOI: 10.1136/bcr-2015-210970

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  A difficult diagnosis.

Authors:  Jan Willem Cohen Tervaert; Coen A Stegeman
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

2.  Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report.

Authors:  Hilda J I de Jong; Ronald H B Meyboom; Markku J Helle; Olaf H Klungel; Leo Niskanen; Jan Willem Cohen Tervaert
Journal:  Ann Intern Med       Date:  2014-10-21       Impact factor: 25.391

3.  A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.

Authors:  Rachel L Gross; Jason Brucker; Asena Bahce-Altuntas; Maria A Abadi; Jules Lipoff; David Kotlyar; Peter Barland; Chaim Putterman
Journal:  Clin Rheumatol       Date:  2011-06-25       Impact factor: 2.980

4.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease.

Authors:  Martina M McGrath; Tamara Isakova; Helmut G Rennke; Ann M Mottola; Karen A Laliberte; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

5.  The hairy-print for levamisole-induced vasculitis.

Authors:  Hélène Lazareth; Gilles Peytavin; Laura Polivka; Nicolas Dupin
Journal:  BMJ Case Rep       Date:  2012-08-08

6.  Early excision and grafting, an alternative approach to the surgical management of large body surface area levamisole-adulterated cocaine induced skin necrosis.

Authors:  Jason Miner; Paul Gruber; Travis L Perry
Journal:  Burns       Date:  2014-12-17       Impact factor: 2.744

7.  Levamisole: a dangerous new cocaine adulterant.

Authors:  A Chang; J Osterloh; J Thomas
Journal:  Clin Pharmacol Ther       Date:  2010-07-28       Impact factor: 6.875

Review 8.  Can you vaccinate against substance abuse?

Authors:  Thomas R Kosten; Coreen B Domingo
Journal:  Expert Opin Biol Ther       Date:  2013-04-18       Impact factor: 4.388

Review 9.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

10.  Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases.

Authors:  Adam Q Carlson; Delphine S Tuot; Kuang-Yu Jen; Brad Butcher; Jonathan Graf; Ramin Sam; John B Imboden
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

View more
  1 in total

Review 1.  [Cocaine-induced vasculitis and mimics of vasculitis].

Authors:  Nikolas Ruffer; Martin Krusche; Konstanze Holl-Ulrich; Ina Kötter; Fabian Lötscher
Journal:  Z Rheumatol       Date:  2022-05-25       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.